Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01055457 · ClinicalTrials.gov registry record · NA
Vistakon Investigational Multi-purpose Contact Lens Care Solution.
A NA study of Contact Lens Wear, sponsored by Johnson & Johnson Vision Care.
- Completed
- Registry status
- NA
- Development phase
- 315
- Enrollment target
- 14
- Study locations
NCT01055457 is a NA study of Contact Lens Wear that has completed, run by Johnson & Johnson Vision Care. The registered enrollment target is 315 participants, roughly in line with the 312-participant average among 3 other Contact Lens Wear trials with a reported enrollment target. The trial reports 14 study locations across 10 states.
The verdict
NCT01055457, a NA study of Contact Lens Wear, has completed, sponsored by Johnson & Johnson Vision Care.
- COMPLETED
- Registry status
- NA
- Development phase
- 315 participants
- Enrollment target
- 14
- Study locations
Study Summary
This study compares an investigational contact lens care multi-purpose solution to a currently marketed multi-purpose solution.
Conditions Studied
Interventions
- DEVICE Vistakon Investigational Multi-Purpose Solution II
- DEVICE ReNu MultiPlus Multi-Purpose Solution
Study Locations (14)
Florida
- - Orlando
- - Tallahassee
New York
- - Jamestown
- - Vestal
Pennsylvania
- - Moon Township
- - State College
Texas
- - Amarillo
- - Katy
California
- - Mission Viejo
Illinois
- - Bloomington
Kansas
- - Pittsburg
Ohio
- - Athens
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 315 participants |
| Start Date | 2009-11-01 |
| Est. Completion | 2010-05-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01055457
The ClinicalTrials.gov registry entry for NCT01055457 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 315 participants, a figure that helps gauge the scale of data the investigators plan to collect, roughly in line with the 312-participant average among 3 other Contact Lens Wear trials with a reported enrollment target. The listed sponsor is Johnson & Johnson Vision Care, which has 142 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Contact Lens Wear appearing as the primary indexed condition, and to 2 interventions - of which Vistakon Investigational Multi-Purpose Solution II is the first listed.
NCT01055457 reports 14 study locations spanning 10 distinct geographic areas - top geographies include Florida, New York, Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT01055457 about?
NCT01055457 is a clinical study titled "Vistakon Investigational Multi-purpose Contact Lens Care Solution.". This study compares an investigational contact lens care multi-purpose solution to a currently marketed multi-purpose solution.
What is the current status of trial NCT01055457?
This trial is currently completed. It is a NA study. The enrollment target is 315 participants. The study started on 2009-11-01. Estimated completion is 2010-05-01.
What conditions does trial NCT01055457 study?
This clinical trial studies the following conditions: Contact Lens Wear.
What interventions are being tested in trial NCT01055457?
The interventions under investigation include: Vistakon Investigational Multi-Purpose Solution II (DEVICE), ReNu MultiPlus Multi-Purpose Solution (DEVICE).
Who is sponsoring clinical trial NCT01055457?
This trial is sponsored by Johnson & Johnson Vision Care, which has 142 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01055457 being conducted?
This trial has 14 study locations across California, Florida, Illinois, Kansas, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Contact Lens Wear
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.